CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment
2016 · Nature Communications · 158 citations
https://doi.org/10.1038/ncomms11674
C
Chieh Tseng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
1.0K
Citations
13
h-index
14
i10-index
Chieh Tseng is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer Cells and Metastasis & Mesenchymal stem cell research & Adipokines, Inflammation, and Metabolic Diseases. The author has an h-index of 13, co-authored 41 publications.
Papers by this author
worksPhase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
2024 · npj Precision Oncology · 9 citations
https://doi.org/10.1038/s41698-024-00634-6
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
2023 · Cancer Chemotherapy and Pharmacology · 6 citations
https://doi.org/10.1007/s00280-023-04545-4
Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterations
2025 · ESMO Open · 3 citations
https://doi.org/10.1016/j.esmoop.2025.104136
Phase I trial of neratinib plus palbociclib in advanced cancers with HER family alterations
2025 · ESMO Open · 0 citations
https://doi.org/10.1016/j.esmoop.2025.105895
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat